BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22568903)

  • 1. Gastrointestinal delivery of anti-inflammatory nanoparticles.
    Laroui H; Sitaraman SV; Merlin D
    Methods Enzymol; 2012; 509():101-25. PubMed ID: 22568903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.
    Laroui H; Dalmasso G; Nguyen HT; Yan Y; Sitaraman SV; Merlin D
    Gastroenterology; 2010 Mar; 138(3):843-53.e1-2. PubMed ID: 19909746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coated chitosan pellets containing rutin intended for the treatment of inflammatory bowel disease: in vitro characteristics and in vivo evaluation.
    Rabišková M; Bautzová T; Gajdziok J; Dvořáčková K; Lamprecht A; Pellequer Y; Spilková J
    Int J Pharm; 2012 Jan; 422(1-2):151-9. PubMed ID: 22079717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality by design approach for developing chitosan-Ca-alginate microspheres for colon delivery of celecoxib-hydroxypropyl-β-cyclodextrin-PVP complex.
    Mennini N; Furlanetto S; Cirri M; Mura P
    Eur J Pharm Biopharm; 2012 Jan; 80(1):67-75. PubMed ID: 21864681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Delivery of Nanoparticles Loaded With Ginger Active Compound, 6-Shogaol, Attenuates Ulcerative Colitis and Promotes Wound Healing in a Murine Model of Ulcerative Colitis.
    Zhang M; Xu C; Liu D; Han MK; Wang L; Merlin D
    J Crohns Colitis; 2018 Jan; 12(2):217-229. PubMed ID: 28961808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing colon-specific delivery systems for anticancer drug-loaded nanoparticles: an evaluation of alginate carriers.
    Ma Y; Coombes AG
    J Biomed Mater Res A; 2014 Sep; 102(9):3167-76. PubMed ID: 24124007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.
    Xiao B; Xu Z; Viennois E; Zhang Y; Zhang Z; Zhang M; Han MK; Kang Y; Merlin D
    Mol Ther; 2017 Jul; 25(7):1628-1640. PubMed ID: 28143741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticles with surface antibody against CD98 and carrying CD98 small interfering RNA reduce colitis in mice.
    Xiao B; Laroui H; Viennois E; Ayyadurai S; Charania MA; Zhang Y; Zhang Z; Baker MT; Zhang B; Gewirtz AT; Merlin D
    Gastroenterology; 2014 May; 146(5):1289-300.e1-19. PubMed ID: 24503126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colon targeted oral drug delivery system based on alginate-chitosan microspheres loaded with icariin in the treatment of ulcerative colitis.
    Wang QS; Wang GF; Zhou J; Gao LN; Cui YL
    Int J Pharm; 2016 Dec; 515(1-2):176-185. PubMed ID: 27713029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro evaluation of ketoprofen controlled release from various formulations.
    Oprea AM; Dumitriu RP; Cheaburu C; Vasile C
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(3):829-35. PubMed ID: 21235124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physically crosslinked alginate/N,O-carboxymethyl chitosan hydrogels with calcium for oral delivery of protein drugs.
    Lin YH; Liang HF; Chung CK; Chen MC; Sung HW
    Biomaterials; 2005 May; 26(14):2105-13. PubMed ID: 15576185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of chitosan/polyguluronate nanoparticles for siRNA delivery.
    Lee DW; Yun KS; Ban HS; Choe W; Lee SK; Lee KY
    J Control Release; 2009 Oct; 139(2):146-52. PubMed ID: 19567259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colon-targeted dexamethasone microcrystals with pH-sensitive chitosan/alginate/Eudragit S multilayers for the treatment of inflammatory bowel disease.
    Oshi MA; Naeem M; Bae J; Kim J; Lee J; Hasan N; Kim W; Im E; Jung Y; Yoo JW
    Carbohydr Polym; 2018 Oct; 198():434-442. PubMed ID: 30093020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-cross-linking biopolymers as injectable in situ forming biodegradable scaffolds.
    Balakrishnan B; Jayakrishnan A
    Biomaterials; 2005 Jun; 26(18):3941-51. PubMed ID: 15626441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alginate-folic acid-modified chitosan nanoparticles for photodynamic detection of intestinal neoplasms.
    Yang SJ; Lin FH; Tsai HM; Lin CF; Chin HC; Wong JM; Shieh MJ
    Biomaterials; 2011 Mar; 32(8):2174-82. PubMed ID: 21163518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro degradation and drug-release properties of water-soluble chitosan cross-linked oxidized sodium alginate core-shell microgels.
    Chen C; Liu M; Lii S; Gao C; Chen J
    J Biomater Sci Polym Ed; 2012; 23(16):2007-24. PubMed ID: 21967992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and cytotoxicity of N,N,N-trimethyl chitosan/alginate beads containing gold nanoparticles.
    Martins AF; Facchi SP; Monteiro JP; Nocchi SR; Silva CT; Nakamura CV; Girotto EM; Rubira AF; Muniz EC
    Int J Biol Macromol; 2015 Jan; 72():466-71. PubMed ID: 25159881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ injectable nano-composite hydrogel composed of curcumin, N,O-carboxymethyl chitosan and oxidized alginate for wound healing application.
    Li X; Chen S; Zhang B; Li M; Diao K; Zhang Z; Li J; Xu Y; Wang X; Chen H
    Int J Pharm; 2012 Nov; 437(1-2):110-9. PubMed ID: 22903048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen.
    Borges O; Silva M; de Sousa A; Borchard G; Junginger HE; Cordeiro-da-Silva A
    Int Immunopharmacol; 2008 Dec; 8(13-14):1773-80. PubMed ID: 18801462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.